Articles Tagged With: liletta
-
Study: Levonorgestrel IUDs Are Safe and Effective for Up to Eight Years
Research continues to show that the 52 mg levonorgestrel IUD is safe and effective for up to eight years of use. It also can decrease bleeding and spotting, and half of the women using the device experienced amenorrhea or infrequent bleeding.
-
Contraceptives Dramatically Decrease Risk of Some Gynecological Cancers
Contraceptives can reduce the risk of some gynecological cancers, including protection against ovarian cancer, endometrial cancer, and uterine cancer. Women who have used oral contraceptives have a lower risk of endometrial and ovarian cancers than women who have never used the product, with a risk reduction of at least 30%.
-
LARC, Pills Can Reduce or Stop Menstrual Bleeding for Extended Periods
Modern contraception offers a variety of benefits to users, in addition to effective pregnancy prevention. Perhaps the most common noncontraceptive reasons people may select some of these hormonal methods is to reduce or stop menstrual bleeding, cramping, and pain.
-
Levonorgestrel IUDs Are Safe and Effective for Eight Years of Use
Two of the most popular hormonal IUDs can be used for eight years, which can make them an even better option for women seeking long-term, highly effective contraception.
-
It Is a New Day for Reproductive Providers
For many in the fields of family planning and reproductive health, it is a new day — but it is not going to be a better day.
-
Data Indicate Efficacy of Liletta IUD for Four Years’ Use
Four-year data from the ongoing multicenter, U.S.-based pivotal trial of the 52 mg Liletta levonorgestrel-releasing intrauterine device (IUD) indicate its safety and efficacy for four years of use in nulliparous and parous women, as well as in non-obese and obese women.
-
Options Expand for Women: FDA Approves a New Intrauterine Device
A new option in intrauterine contraception has been approved: the LILETTA intrauterine device.